Doxobron is a mucolytic and bronchodilatory medicine used for the effective management of respiratory conditions associated with excessive or thick bronchial secretions. It helps reduce mucus viscosity and supports easier expectoration, thereby improving airflow and respiratory comfort. Doxobron is commonly indicated in acute and chronic bronchitis, bronchial asthma with mucus retention, chronic obstructive pulmonary disease (COPD), and other respiratory tract infections where mucus clearance is impaired. By promoting bronchodilation and enhancing mucociliary function, it helps relieve chest congestion, coughing, and breathing difficulty. Doxobron plays an important role in respiratory care by improving airway clearance and supporting better lung function in patients with productive cough and obstructive airway conditions.